BLAB Stock Overview
Engages in the provision of product testing, safety assessment, and compliance services primarily to the cosmetics, consumer packaged and household goods, and nutraceutical industries in the United Kingdom and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Britannia Life Sciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.05 |
| 52 Week High | CA$0.11 |
| 52 Week Low | CA$0.03 |
| Beta | 0.46 |
| 11 Month Change | -16.67% |
| 3 Month Change | n/a |
| 1 Year Change | -9.09% |
| 33 Year Change | -76.74% |
| 5 Year Change | n/a |
| Change since IPO | -81.48% |
Recent News & Updates
Recent updates
Britannia Life Sciences (CSE:BLAB) Shareholders Will Want The ROCE Trajectory To Continue
Mar 01
Britannia Life Sciences (CSE:BLAB) Might Have The Makings Of A Multi-Bagger
Nov 14Returns At Britannia Life Sciences (CSE:BLAB) Appear To Be Weighed Down
Apr 19A Look At The Fair Value Of Britannia Life Sciences Inc. (CSE:BLAB)
Mar 13Shareholder Returns
| BLAB | CA Professional Services | CA Market | |
|---|---|---|---|
| 7D | 0% | -4.2% | 0.2% |
| 1Y | -9.1% | 18.4% | 21.0% |
Return vs Industry: BLAB underperformed the Canadian Professional Services industry which returned 20.9% over the past year.
Return vs Market: BLAB underperformed the Canadian Market which returned 20.2% over the past year.
Price Volatility
| BLAB volatility | |
|---|---|
| BLAB Average Weekly Movement | n/a |
| Professional Services Industry Average Movement | 5.4% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.5% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: BLAB's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine BLAB's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Pete Shippen | britannia.life |
Britannia Life Sciences Inc. engages in the provision of product testing, safety assessment, and compliance services primarily to the cosmetics, consumer packaged and household goods, and nutraceutical industries in the United Kingdom and internationally. The company is headquartered in Toronto, Canada.
Britannia Life Sciences Inc. Fundamentals Summary
| BLAB fundamental statistics | |
|---|---|
| Market cap | CA$4.87m |
| Earnings (TTM) | -CA$5.39m |
| Revenue (TTM) | CA$7.38m |
1.1x
P/S Ratio-1.5x
P/E RatioIs BLAB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BLAB income statement (TTM) | |
|---|---|
| Revenue | CA$7.38m |
| Cost of Revenue | CA$2.81m |
| Gross Profit | CA$4.57m |
| Other Expenses | CA$9.96m |
| Earnings | -CA$5.39m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.033 |
| Gross Margin | 61.95% |
| Net Profit Margin | -72.99% |
| Debt/Equity Ratio | 104.4% |
How did BLAB perform over the long term?
See historical performance and comparison